Skip to Main Content

Breast Cancer

Clinical Research Team

  • Objectives

    • Provide expert multidisciplinary care and identification of therapeutic clinical trials for patient with breast cancer.
    • Increase access to novel treatment strategies for patients with all stages of breast cancer including:
    • Early-stage de-escalation
    • Targeted therapies and immunotherapies
    • Locoregional therapies
    • Build multi-disciplinary research program to better serve catchment area and provide foundation for innovative research within the entire continuum of breast care.

    Research Team Meetings: Friday @ 12pm - 1pm

Breast Team Leader

  • Professor of Internal Medicine (Medical Oncology); Director, Center for Breast Cancer; Chief, Breast Medical Oncology

    Maryam Lustberg, MD, MPH, is Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology at Yale Cancer Center. She is also a Professor of Medicine (Medical Oncology). She has been recognized for her patient-focused care with awards that include being rated by Forbes as one of the top breast medical oncologists in the nation and named to the Castle Connolly list of “Regional Top Doctors,” and “Exceptional Women in Medicine” for 2020. She is currently participating in the American Society of Clinical Oncology (ASCO) Leadership Development Program. Learn more about Dr. Lustberg>> With an emphasis on improving the long-term outcomes for patients with breast cancer who have developed side effects associated with treatment, Dr. Lustberg will continue her research efforts at Yale. She is also focused on...

Members

  • Professor of Internal Medicine (Medical Oncology); Chair, Breast Cancer Tumor Board, Yale Cancer Center; Curriculum Director, Office of Education; Thread Leader, Pharmacology, Office of Education; Master Course Co-Leader, Office of Education

    Research Interests
    • Breast Neoplasms
    • Clinical Trial
    • Medical Oncology
    • Pharmacology
    • Signal Transduction
    • Protein-Tyrosine Kinases
  • Professor of Internal Medicine (Medical Oncology); Director, Clinical Trials Office; Chief Clinical Research Officer, Yale Cancer Center; Associate Director, Clinical Sciences, Yale Cancer Center

    Research Interests
    • Breast Diseases
  • Professor of Internal Medicine (Medical Oncology); Director, Center for Breast Cancer; Chief, Breast Medical Oncology

    Research Interests
    • Chemotherapy-Related Cognitive Impairment
    • Breast Neoplasms
    • Cancer Survivors
  • Professor of Medicine (Medical Oncology); Co-Leader, Genetics, Genomics and Epigenetics, Yale Cancer Center

    Research Interests
    • Breast
    • Breast Neoplasms
    • Genetics
    • Genomics
    • Medical Oncology
    • Translational Research, Biomedical
  • Associate Professor of Medicine (Medical Oncology); Chief, Patient Experience Officer; Medical Director, Survivorship Clinic

    Research Interests
    • Breast Diseases
    • Communication
    • Survivorship
  • Associate Professor of Medicine (Medical Oncology); Chief , Ambulatory Services ; Chief Ambulatory Officer, Smilow Cancer Hospital, Smilow Cancer Hospital; Regional Service Line Medical Director, Central Shoreline Region, Smilow Cancer Hospital

  • Alfred Gilman Professor of Pharmacology and Professor of Medicine (Medical Oncology); Director, Yale Cancer Center; President and Physician-in-Chief, Smilow Cancer Hospital; Deputy Dean for Cancer Research, Yale School of Medicine

    Research Interests
    • Breast